SAR studies on new bis-aryls 5-HT7 ligands: Synthesis and molecular modeling
摘要:
Structure-activity relationships of a series of bis-arylic compounds, investigated as 5-HT7R ligands, are reported. The main structural modifications involved a central aryl moiety (phenyl, pyridine, diazine, triazine) and the nature and position of an amine-containing aliphatic chain. The affinity of the synthesized compounds (26 nM-10 mu M) was systematically correlated with other previously reported series of bis-arylic ligands and rationalized by a ligand-based pharmacophore approach. (C) 2010 Elsevier Ltd. All rights reserved.
SAR studies on new bis-aryls 5-HT7 ligands: Synthesis and molecular modeling
摘要:
Structure-activity relationships of a series of bis-arylic compounds, investigated as 5-HT7R ligands, are reported. The main structural modifications involved a central aryl moiety (phenyl, pyridine, diazine, triazine) and the nature and position of an amine-containing aliphatic chain. The affinity of the synthesized compounds (26 nM-10 mu M) was systematically correlated with other previously reported series of bis-arylic ligands and rationalized by a ligand-based pharmacophore approach. (C) 2010 Elsevier Ltd. All rights reserved.
[EN] MODULATORS OF NUCLEAR RECEPTOR CO-REGULATORY PROTEIN BINDING<br/>[FR] MODULATEURS DE LIAISON PROTÉINIQUE DE CORÉGULATION DE RÉCEPTEUR NUCLÉAIRE
申请人:UNIV NORTHEASTERN
公开号:WO2009117739A1
公开(公告)日:2009-09-24
Disclosed are novel compounds and compositions for inhibition of androgen and estrogen receptor signaling, methods for inhibiting androgen signaling, methods for inhibiting estrogen signaling, methods for inhibiting the interaction between a co-regulatory protein and an androgen or estrogen receptor, and methods for treating cancer.
MODULATORS OF NUCLEAR RECEPTOR CO-REGULATORY PROTEIN BINDING
申请人:Hanson Robert N.
公开号:US20110105608A1
公开(公告)日:2011-05-05
Disclosed are novel compounds and compositions for inhibition of androgen and estrogen receptor signaling, methods for inhibiting androgen signaling, methods for inhibiting estrogen signaling, methods for inhibiting the interaction between a co-regulatory protein and an androgen or estrogen receptor, and methods for treating cancer.
[EN] PROCESS FOR PREPARING TRI-ARYL-ALKYLALKENES<br/>[FR] PROCEDE DE PREPARATION DE TRI-ARYL-ALKYLALCENES
申请人:SMITHKLINE BEECHAM PLC
公开号:WO1999002509A1
公开(公告)日:1999-01-21
(EN) A process for preparing tri-arylalkylalkenes of formula (I) wherein Ar1, Ar2 and Ar3 can be the same or different aromatic groups. R1 is alkyl or substituted alkyl, by heating in a solvent a compound of the formula (II) wherein -COR2 is an acyl derivative.(FR) L'invention concerne un procédé de préparation de tri-aryl-alkylalcènes représentés par la formule générale (I). On obtient ces tri-aryl-alkylalcènes en chauffant dans un solvant un composé représenté par la formule spécifique (II). Dans la formule générale (I), Ar1, Ar2 et Ar3 peuvent être des groupes aromatiques identiques ou différents. R1 est alkyle ou alkyle substitué. Dans la formule spécifique (II), -COR2 est un dérivé acyle.
SAR studies on new bis-aryls 5-HT7 ligands: Synthesis and molecular modeling
作者:Eduard Badarau、Ryszard Bugno、Franck Suzenet、Andrzej J. Bojarski、Adriana-Luminita Finaru、Gérald Guillaumet
DOI:10.1016/j.bmc.2010.01.035
日期:2010.3
Structure-activity relationships of a series of bis-arylic compounds, investigated as 5-HT7R ligands, are reported. The main structural modifications involved a central aryl moiety (phenyl, pyridine, diazine, triazine) and the nature and position of an amine-containing aliphatic chain. The affinity of the synthesized compounds (26 nM-10 mu M) was systematically correlated with other previously reported series of bis-arylic ligands and rationalized by a ligand-based pharmacophore approach. (C) 2010 Elsevier Ltd. All rights reserved.